These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 38097671)

  • 1. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
    Taïeb D; Nölting S; Perrier ND; Fassnacht M; Carrasquillo JA; Grossman AB; Clifton-Bligh R; Wanna GB; Schwam ZG; Amar L; Bourdeau I; Casey RT; Crona J; Deal CL; Del Rivero J; Duh QY; Eisenhofer G; Fojo T; Ghayee HK; Gimenez-Roqueplo AP; Gill AJ; Hicks R; Imperiale A; Jha A; Kerstens MN; de Krijger RR; Lacroix A; Lazurova I; Lin FI; Lussey-Lepoutre C; Maher ER; Mete O; Naruse M; Nilubol N; Robledo M; Sebag F; Shah NS; Tanabe A; Thompson GB; Timmers HJLM; Widimsky J; Young WJ; Meuter L; Lenders JWM; Pacak K
    Nat Rev Endocrinol; 2024 Mar; 20(3):168-184. PubMed ID: 38097671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
    van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
    Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
    Taïeb D; Wanna GB; Ahmad M; Lussey-Lepoutre C; Perrier ND; Nölting S; Amar L; Timmers HJLM; Schwam ZG; Estrera AL; Lim M; Pollom EL; Vitzthum L; Bourdeau I; Casey RT; Castinetti F; Clifton-Bligh R; Corssmit EPM; de Krijger RR; Del Rivero J; Eisenhofer G; Ghayee HK; Gimenez-Roqueplo AP; Grossman A; Imperiale A; Jansen JC; Jha A; Kerstens MN; Kunst HPM; Liu JK; Maher ER; Marchioni D; Mercado-Asis LB; Mete O; Naruse M; Nilubol N; Pandit-Taskar N; Sebag F; Tanabe A; Widimsky J; Meuter L; Lenders JWM; Pacak K
    Lancet Diabetes Endocrinol; 2023 May; 11(5):345-361. PubMed ID: 37011647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
    Fischer A; Kloos S; Maccio U; Friemel J; Remde H; Fassnacht M; Pamporaki C; Eisenhofer G; Timmers HJLM; Robledo M; Fliedner SMJ; Wang K; Maurer J; Reul A; Zitzmann K; Bechmann N; Žygienė G; Richter S; Hantel C; Vetter D; Lehmann K; Mohr H; Pellegata NS; Ullrich M; Pietzsch J; Ziegler CG; Bornstein SR; Kroiss M; Reincke M; Pacak K; Grossman AB; Beuschlein F; Nölting S
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2676-2685. PubMed ID: 36946182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of an Adult Zebrafish Model for
    Miltenburg JB; Gorissen M; van Outersterp I; Versteeg I; Nowak A; Rodenburg RJ; van Herwaarden AE; Olthaar AJ; Kusters B; Conrad C; Timmers HJLM; Dona M
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
    Andrews KA; Ascher DB; Pires DEV; Barnes DR; Vialard L; Casey RT; Bradshaw N; Adlard J; Aylwin S; Brennan P; Brewer C; Cole T; Cook JA; Davidson R; Donaldson A; Fryer A; Greenhalgh L; Hodgson SV; Irving R; Lalloo F; McConachie M; McConnell VPM; Morrison PJ; Murday V; Park SM; Simpson HL; Snape K; Stewart S; Tomkins SE; Wallis Y; Izatt L; Goudie D; Lindsay RS; Perry CG; Woodward ER; Antoniou AC; Maher ER
    J Med Genet; 2018 Jun; 55(6):384-394. PubMed ID: 29386252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas.
    Wallace PW; Conrad C; Brückmann S; Pang Y; Caleiras E; Murakami M; Korpershoek E; Zhuang Z; Rapizzi E; Kroiss M; Gudziol V; Timmers HJ; Mannelli M; Pietzsch J; Beuschlein F; Pacak K; Robledo M; Klink B; Peitzsch M; Gill AJ; Tischler AS; de Krijger RR; Papathomas T; Aust D; Eisenhofer G; Richter S
    J Pathol; 2020 Aug; 251(4):378-387. PubMed ID: 32462735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma.
    Sue M; Martucci V; Frey F; Lenders JM; Timmers HJ; Peczkowska M; Prejbisz A; Swantje B; Bornstein SR; Arlt W; Fassnacht M; Beuschlein F; Robledo M; Pacak K; Eisenhofer G
    Eur J Endocrinol; 2015 Feb; 172(2):89-95. PubMed ID: 25371406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations.
    Bernardo-Castiñeira C; Valdés N; Celada L; Martinez ASJ; Sáenz-de-Santa-María I; Bayón GF; Fernández AF; Sierra MI; Fraga MF; Astudillo A; Jiménez-Fonseca P; Rial JC; Hevia MÁ; Turienzo E; Bernardo C; Forga L; Tena I; Molina-Garrido MJ; Cacho L; Villabona C; Serrano T; Scola B; Chirivella I; Del Olmo M; Menéndez CL; Navarro E; Tous M; Vallejo A; Athimulam S; Bancos I; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5673-5692. PubMed ID: 31216007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
    Kuo MJM; Nazari MA; Jha A; Pacak K
    Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.
    Gupta S; Erickson LA
    Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
    Eisenhofer G; Lenders JW; Siegert G; Bornstein SR; Friberg P; Milosevic D; Mannelli M; Linehan WM; Adams K; Timmers HJ; Pacak K
    Eur J Cancer; 2012 Jul; 48(11):1739-49. PubMed ID: 22036874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
    Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
    Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International initiative for a curated
    Ben Aim L; Maher ER; Cascon A; Barlier A; Giraud S; Ercolino T; Pigny P; Clifton-Bligh RJ; Mirebeau-Prunier D; Mohamed A; Favier J; Gimenez-Roqueplo AP; Schiavi F; Toledo RA; Dahia PL; Robledo M; Bayley JP; Burnichon N
    J Med Genet; 2022 Aug; 59(8):785-792. PubMed ID: 34452955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas.
    Petenuci J; Guimaraes AG; Fagundes GFC; Benedetti AFF; Afonso ACF; Pereira MAA; Zerbini MCN; Siqueira S; Yamauchi F; Soares SC; Srougi V; Tanno FY; Chambo JL; Lopes RI; Denes FT; Hoff AO; Latronico AC; Mendonca BB; Fragoso MCBV; Almeida MQ
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):117-124. PubMed ID: 33745191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.